Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JAK inhibitors
Pharma
Incyte wins injunction to block Sun's Leqselvi launch
Despite winning an alopecia approval for its drug Leqselvi in July, Sun Pharma will have to wait a while longer to launch its JAK inhibitor.
Fraiser Kansteiner
Nov 4, 2024 10:01am
Incyte eyes upcoming launches as Jakafi's patent cliff nears
Oct 29, 2024 5:07pm
Incyte, Syndax bag FDA nod for potential GvHD blockbuster
Aug 14, 2024 5:15pm
Incyte finds fun in pharma ad fatigue in Opzelura TV spot
Aug 6, 2024 6:45am
Leo Pharma builds its case for JAK inhibitor cream delgocitinib
Jan 24, 2024 10:36am
Incyte defends Jakafi against competitor drugs, patent cliff
Oct 31, 2023 11:23am
